A comparison of fluvoxamine and fluoxetine in the treatment of major depression

Journal of Clinical Psychopharmacology

Volumn 16, Issue 5, 1996, Pages 373-378

  Rapaport, Mark ^a   Coccaro, Emil ^b   Sheline, Yvette ^c   Perse, Teri ^d   Holland, Peter ^e   Fabre, Louis ^f   Bradford, Dianne ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d New Frontiers Professional Center   (United States)

^e Boca Raton Psychiatric Group   (United States)

^f Research Testing Inc   (United States)

^g Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; NAUSEA; SEROTONIN UPTAKE INHIBITORS;

EID: 0029803016     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199610000-00005     Document Type: Article

References (19)

1. Benfield P, Ward A. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986;32:313-34.
2. Grimsley SR, Jann MW. Paroxetine, sertraline, and fluvoxamine - new selective serotonin reuptake inhibitors. Clin Pharmacol 1992;11:930-95.
3. Wilde MI, Plosker GL, Benfield P. Fluvoxamine. An updated review of its pharmacology and therapeutic use in depressive illness. Drugs 1993;46:895-924.
4. Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993;306:683-7.
5. Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990;51[12, suppl B]:9-12.
6. Beasley CM Jr., Sayler ME, Weiss AL, Potvin JH. Fluoxetine: activating and sedating effects at multiple fixed doses. J Clin Psychopharmacol 1992;12:328-33.
7. Miller IW, Norman WH, Dow MG, Bishop SB. The Modified Scale for Suicidal Ideation: reliability and validity. J Consult Clin Psychol 1986;724-5.
8. Hamilton M. Development of a rating scale for primary depressive illness. Brit J Soc Clin Psychol 1967;6:278-96.
9. Guy W. ECDEU assessment manual for psychopharmacology. Rockville, MD: US Department of Health, Education and Welfare, 1976;337-40.
10. Hamilton M. The assessment of anxiety states by rating. Brit J Med Psychol 1959;32:50-5.
11. Raskin A. Replication of factors of psychopathology in interview, ward behavior and self-report ratings of hospitalized depressives. J Nerv Ment Dis 1969;148:87-8.
12. Lipman RS, Covi L, Downing RW, et al. Pharmacotherapy of anxiety and depression: rationale and study design. Psychopharmacol Bull 1981;17:91-4.
13. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1-15.
14. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-6.
15. COSTART - Coding Symbols for a Thesaurus of Adverse Reaction Terms. National adverse drug reaction dictionary. Rockville, MD: Department of Health, Education and Welfare, Public Health Service, Food and Drug Administration. US Government Printing Office, 4th edition.
16. Royal Pharmaceutical Society of Great Britain. Martindale: the extra pharmacopoeia (30th ed.). London: The Pharmaceutical Press, 1993.
17. Edwards JG, Inman WHW, Wilton L, Pearce GL. Prescription-event monitoring of 10,401 patients treated with fluvoxamine. Br J Psychiatry 1994;164:387-95.
18. Beasley CM Jr., Dornseif BE, Pultz JA, Bosomworth JC, Sayler ME. Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry 1991;52:294-9.
19. Beasley CM Jr., Sayler ME, Bosomworth JC, Wernicke JF. High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression. J Clin Psychopharmacol 1991; 11:166-74.